4//SEC Filing
Edwards Lifesciences Corp 4
Accession 0001225208-12-010386
$EWCIK 0001099800operating
Filed
Apr 26, 8:00 PM ET
Accepted
Apr 27, 8:49 PM ET
Size
10.9 KB
Accession
0001225208-12-010386
Insider Transaction Report
Form 4
REINDL ROBERT C
CVP, H.R. and Communications
Transactions
- Sale
Common Stock
2012-04-25$80.96/sh−17,701$1,433,073→ 5,776 total - Sale
Common Stock
2012-04-25$82.29/sh−6,799$559,490→ 23,477 total - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2012-04-25−24,500→ 0 totalExercise: $22.95From: 2006-05-12Exp: 2012-05-11→ Common Stock (24,500 underlying) - Exercise/Conversion
Common Stock
2012-04-25$22.95/sh+24,500$562,275→ 30,276 total
Footnotes (4)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2012.
- [F2]This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
- [F3]This transaction was executed in multiple trades at prices ranging from $82.00 to $82.84. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $80.00 to $81.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Edwards Lifesciences Corp
CIK 0001099800
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001099800
Filing Metadata
- Form type
- 4
- Filed
- Apr 26, 8:00 PM ET
- Accepted
- Apr 27, 8:49 PM ET
- Size
- 10.9 KB